// App-Quantinova.ai

5070 : Defining more precisely the effects of docetaxel plus ADT for men with mHSPC Meta-analysis of individual participant data from randomized trials.

Researchers

Presenter

  • Claire Louise Vale

Principal Investigators

  • Peter Godolphin

  • Larysa H Rydzewska

  • Jean-Marie Boher

  • Sarah Burdett

  • Yu-Hui Chen

  • Gwenaelle Gravis

  • Nicholas D. James

  • Glenn Liu

  • Laura Murphy

  • Mahesh K. B. Parmar

  • Ewelina Rogozinska

  • Patrick Sfumato

  • Christopher Sweeney

  • Matthew R. Sydes

  • Bertrand F. Tombal

  • Ian R White

  • Jayne F. Tierney

Medical Centers

  • MRC Clinical Trials Unit, UCL, London, United Kingdom

  • Institut Paoli-Calmettes, Marseille, France

  • Dana-Farber Cancer Institute, Boston, MA

  • Biostatistic, Institut Paoli-Calmettes, Aix-Marseille Universite, Marseille, France

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • Institut Paoli-Calmettes, Marseille, France

  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA

  • Institut de Recherche Clinique, Universite Catholique de Louvain, Brussels, Belgium

Locations

  • United Kingdom

  • France

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved